Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Arterial hypertension is associated with increased cardiovascular morbidity and mortality. Although blood pressure-lowering therapies significantly reduce the risk of major cardiovascular events, blood pressure control remains unsatisfactorily low. Several device-based antihypertensive therapies have been investigated in patients with treatment-resistant hypertension and in patients unable or unwilling to adhere to antihypertensive medication. As the field of device-based therapies is subject to constant change, this review aims at providing an up-to-date overview of different device-based approaches for the treatment of hypertension. These approaches target the sympathetic nervous system (renal denervation, baroreflex amplification therapy, baroreflex activation therapy, and carotid body ablation) or alter mechanical arterial properties by creating an iliac arteriovenous fistula. Notably, the use of all of these treatment options is not recommended for the routine treatment of hypertension by current guidelines but should be investigated in the context of controlled clinical studies. © American Journal of Hypertension, Ltd 2019. All rights reserved. For Permissions, please email:


Michael Kunz, Lucas Lauder, Sebastian Ewen, Michael Böhm, Felix Mahfoud. The Current Status of Devices for the Treatment of Resistant Hypertension. American journal of hypertension. 2020 Jan 01;33(1):10-18

Expand section icon Mesh Tags

PMID: 31570933

View Full Text